News

Find News

Filter articles

Applied Filters

Showing 91 to 100 of 730 results

Sanofi collaborates with Biomunex to develop antibody therapeutics

France15-01-2019

Multinational pharmaceutical company Sanofi has entered into a licensing agreement with Paris-based biopharmaceutical company Biomunex.

Surge in life sciences investment in Catalonia: report

EU, Spain10-01-2019

The number of international investors in life sciences start-ups in the Catalonia region in Spain has multiplied by ten in the last five years, according to a new report.

US Supreme Court refuses to hear appeal against ‘unclean hands’ decision

US10-01-2019

The US Supreme Court has refused to hear an appeal against a ruling that American pharmaceutical firm Merck & Co cannot collect $200 million in damages due to its misconduct during a trial.

Locus licenses CRISPR tech to Janssen in potential $818m deal

Belgium, US09-01-2019

US-based Locus Biosciences has announced it will license its CRISPR-Cas3 technology to Janssen, a subsidiary of American pharmaceutical company Johnson & Johnson, in a deal worth a potential $818 million.

Pierce Bainbridge adds two partners to NY office

US09-01-2019

Los Angeles-based law firm Pierce Bainbridge Beck Price & Hecht has hired two partners to its New York office.

Indian Supreme Court reinstates Monsanto GM cotton seed patent

India08-01-2019

The Supreme Court of India has ruled that biotechnology company Monsanto’s patent for genetically modified cotton seeds is valid and enforceable in the country.

Court invalidates Illumina patents in Ariosa row

US02-01-2019

Ariosa Diagnostics, a subsidiary of Swiss healthcare firm Roche, has won a patent dispute with American biotechnology firm Illumina.

Ballard Spahr adds partner from McCarter & English

US19-12-2018

John Zurawski has joined Ballard Spahr as a partner in Philadelphia, after spending more than two years at McCarter & English.

Pfizer inks licensing deal with Seattle biotech firm

US18-12-2018

Pfizer and Seattle-based biotech company Kineta Immuno-Oncology have signed a research and licensing agreement worth a potential $520 million.

Holland & Hart adds ex-biologist as of counsel

US17-12-2018

Holland & Hart has added Rachel Carnaggio, of counsel, to its Denver office in Colorado.

Showing 91 to 100 of 730 results

LSIPR